Skip to main content
Caplight Logo









BlueSignum

BlueSignum

Private
SeoulHealthcare & Life Scienceshttps://www.bluesignum.com/en

Last Round

Seed

May 15, 2023

Total Funding Raised

$1.24M

Company Overview

BlueSignum is a healthcare technology company that develops AI-powered mobile applications for mood tracking, self-reflection, and mental health support.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, NLP & Conversational AI, Patient Engagement, Medical AI

Business Model

B2C

Customer Profile

Freemium, Subscription SaaS

AI Layer

Application

Keywords

mental health appmood trackingcognitive behavioral therapyCBTdigital wellnessAI therapyself-care appmental wellnesshabit trackerconversational AIstress managementpocket therapistworkforce wellnessemployee mental healthteletherapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BlueSignum Comparables

Compare BlueSignum with similar companies based on industry and business-model similarity.

BlueSignum comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stoic Routine
87%
Daylio
83%
Youper
83%

BlueSignum Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 15, 2023
GrantJul 1, 2022
SeedDec 23, 2020

Key People

Founding team and executive leadership

HyeonWook Park

CEO Staff

Executive Team

Sang Lee

부대표, COO

Executive Team

BlueSignum Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2023

    Raised $864K led by Korea Investment Partners

  • Jul 1, 2022

    $380K grant received from TIPS

BlueSignum Filings

Explore SEC and related filing metadata, where available.

BlueSignum filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BlueSignum's valuation, stock price, and market status.

Is BlueSignum a public or private company?

BlueSignum is a private company.

What is the current stock price of BlueSignum?

BlueSignum is a private company with no public stock price. No recent secondary market data is available.

How much is BlueSignum worth (valuation)?

Valuation information for BlueSignum is not publicly available.

Can I buy BlueSignum stock?

BlueSignum shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BlueSignum's last funding round?

BlueSignum's most recent funding round was Seed on May 15, 2023.

Who are the main investors in BlueSignum?

Key investors in BlueSignum include Korea Investment Partners.

Will BlueSignum IPO soon?

No public IPO plans have been announced for BlueSignum.

How can I track BlueSignum secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BlueSignum's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range13
Year Founded2020
Last FundingMay 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?